课题基金 / 基金详情

项目摘要

项目成果

RAYMOND J DINGLEDINE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Status epilepticus (SE) in man and rodents can produce cognitive deficits and trigger a series of molecular and cellular events that eventually culminate in the appearance of spontaneous seizures, i.e., epilepsy. An early event in this process appears to be engaged by the transcriptional repressor, REST. Our hypothesis, supported by preliminary evidence, is that REST induction by status epilepticus regulates many aspects of epileptogenesis, including neurodegeneration, cognitive impairments, neurogenesis and the development of spontaneous seizures. Specific aims are 1) To identify the principal set of genes expressed by dentate granule cells that are directly regulated by REST after SE, and to compare the effect of conditional mutation of HDAC2 and G9a, and inhibition of class I HDACs, G9a histone methyltransferase and LSD1/SMCX histone demethylase, on their SE-induced, REST-mediated transcriptional profile. 2) To determine whether conditional mutation of REST in a subset of forebrain neurons blunts the neurodegeneration, cognitive deficits, and neurogenesis that occur after SE. 3) To compare the ability of conditional mutation of REST and (depending on the outcome of aim 1) conditional mutation or post-SE inhibition of HDAC2, G9a, and LSD1, to reduce the development of epilepsy after SE. A comparison of the pilocarpine and kainate SE models will be done to minimize model-specific conclusions. Both genetic and pharmacologic approaches will be used to pursue these aims. Strategies will involve conditional mutations of REST, HDAC2 and G9a, together with selective inhibitors of the REST epigenetic effector enzymes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optimization of EP2 Antagonists for Post-Seizure Cognitive Deficits
  • 批准号:
    10467539
  • 项目类别:
  • 资助金额:
    $67.75万
  • 财政年份:
    2022
  • 负责人:
    RAYMOND J DINGLEDINE
  • 依托单位:
Optimization of EP2 Antagonists for Post-Seizure Cognitive Deficits
  • 批准号:
    10732636
  • 项目类别:
  • 资助金额:
    $67.95万
  • 财政年份:
    2022
  • 负责人:
    RAYMOND J DINGLEDINE
  • 依托单位:
Exploiting EP2 receptor biology to target seizure-related neuroinflammation selectively
  • 批准号:
    10356163
  • 项目类别:
  • 资助金额:
    $52.02万
  • 财政年份:
    2020
  • 负责人:
    RAYMOND J DINGLEDINE
  • 依托单位:
Exploiting EP2 receptor biology to target seizure-related neuroinflammation selectively
  • 批准号:
    10171930
  • 项目类别:
  • 资助金额:
    $52.02万
  • 财政年份:
    2020
  • 负责人:
    RAYMOND J DINGLEDINE
  • 依托单位:
海外基金